ID

26167

Beschreibung

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 End of Re-Enrollment Titration Period

Stichworte

Versionen (1)
  1. 10/10/17 10/10/17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

10 ottobre 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC-ND 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

Englisch

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 Formulare  
Patient Information
Beschreibung

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Beschreibung

Patient Number

Datentyp

text

Alias
UMLS CUI [1]
C1830427
Date of Visit
Beschreibung

Date of Visit

Datentyp

date

Maßeinheiten
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1320303
dd-mmm-yyyy
End of Re-Enrollment Titration Period
Beschreibung

End of Re-Enrollment Titration Period

Alias
UMLS CUI-1
C1516879
UMLS CUI-2
C1272693
UMLS CUI-3
C2983683
Dose of Study Medication prescribed for Maintenance period:
Beschreibung

Dosage of study drug

Datentyp

float

Maßeinheiten
  • mg/d
Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
mg/d
At which week did Titration end?
Beschreibung

End Date of Titration

Datentyp

float

Maßeinheiten
  • week
Alias
UMLS CUI [1,1]
C2983683
UMLS CUI [1,2]
C0806020
week
Investigator Signature
Beschreibung

Investigator Signature

Alias
UMLS CUI-1
C2346576
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
Beschreibung

Signature

Datentyp

text

Alias
UMLS CUI [1]
C1519316
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
Beschreibung

Investigator's Name

Datentyp

text

Alias
UMLS CUI [1]
C2826892
Date
Beschreibung

Date of Report

Datentyp

date

Maßeinheiten
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yyyy
Zum Seitenanfang zurückkehren

Ähnliche Modelle

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
End of Re-Enrollment Titration Period
C1516879 (UMLS CUI-1)
C1272693 (UMLS CUI-2)
C2983683 (UMLS CUI-3)
Dosage of study drug
Item
Dose of Study Medication prescribed for Maintenance period:
float
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
End Date of Titration
Item
At which week did Titration end?
float
C2983683 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Signature
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
text
C1519316 (UMLS CUI [1])
Investigator's Name
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
text
C2826892 (UMLS CUI [1])
Date of Report
Item
Date
date
C1302584 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video